Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation — VAD  

Ventricular Assist Device Clinical Trial

Official title: Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation

Status Completed

Clinical Trial Summary

The frailty syndrome is important to consider in perioperative cardiac assistance. One of its components is the patient's sarcopenia. This can be assessed by measuring the size of the psoas muscle. For this purpose, one of the most studied measures seems to be the measurement of the Psoas Index. This is a contouring of the psoas muscle, performed on an axial section of a CT scan, at the level of the L4 vertebra, which is then matched to the body surface. However, there is no standardization of measurements and volume acquisitions, and different image processing is also described. A radiological evaluation of the psoas could overcome this difficulty and provide a rapid and available screening tool for sarcopenia.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Ventricular Assist Device

• NCT number: NCT05612555
• Study type: Observational
• Source: University Hospital, Strasbourg, France
• Status: Completed
• Start date: September 9, 2019
• Completion date: September 9, 2020